- Home
- / APEX
APEX
Stock Price
NT$29.1
2024-10-29
Market Capitalization
NT$2.9 B
2024-10-29
Revenue
NT$1.9 B
FY, 2025
APEX Summary
Company Summary
- Overview
- APEX is a provider of healthcare products and solutions. It offers hemoglobin screening, glucose, and blood ketone monitoring systems, point of care (POC) analyzers, etc.
- Type
- Public
- Status
- Active
- Founded
- 1997
- Website
- https://www.apexbio.com
- Cybersecurity rating
Table of Contents
APEX Financials
Summary Financials
- Revenue (Q1, 2026)
- NT$519.7M
- Gross profit (Q1, 2026)
- NT$190.5M
- Net income (Q1, 2026)
- NT$81.4M
- Cash (Q1, 2026)
- NT$594.0M
- EBIT (Q1, 2026)
- NT$78.3M
- Enterprise value
- $2.5B
Competitors and Similar Companies
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026